• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Risk of late radiation necrosis more than 5 years after stereotactic radiosurgery.

作者信息

McCall Neal S, Lu Annabel, Hopkins Benjamin D, Qian David, Hoang Kimberly B, Olson Jeffrey J, Zhong Jim, Eaton Bree R, Shu Hui-Kuo G

机构信息

Departments of1Radiation Oncology and.

2Department of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.

出版信息

J Neurosurg. 2024 Nov 1;142(4):1117-1124. doi: 10.3171/2024.6.JNS232187. Print 2025 Apr 1.

DOI:10.3171/2024.6.JNS232187
PMID:39486061
Abstract

OBJECTIVE

Radiation necrosis (RN) is a well-recognized late complication most commonly occurring within 2 years of stereotactic radiosurgery (SRS); however, late RN (LRN), RN occurring or recurring > 5 years after SRS, has been poorly described. This study analyzes the incidence of and risk factors for LRN occurring > 5 years after SRS.

METHODS

This retrospective analysis included patients treated with linear accelerator-based SRS for tumors or arteriovenous malformations with > 5 years of clinical and serial MRI follow-up. LRN was defined as new neurological symptoms with neuroanatomically correlated imaging findings without disease recurrence. Univariate and multivariate analyses for LRN were performed using the Cox proportional hazards model.

RESULTS

The authors identified a cumulative 297 lesions in 219 patients treated to a median dose of 17 Gy with a median follow-up of 7.4 years. In total, 290 (97.6%) lesions were treated in a single fraction, and 64 (21.5%) were treated after resection. The LRN occurred in 19 (8.7%) patients and in 23 (7.7%) lesions at a median of 6.1 years (range 5.1-13.9 years) after SRS. Fifteen of the 23 (65.2%) lesions were managed with steroids, bevacizumab, and/or antiepileptic drugs. The remaining 8 (34.8%) were resected; histopathology confirmed necrosis without disease recurrence in each. On multivariate analysis, only > 5-cm3 volume of the brain receiving 12 Gy (brain V12Gy) (HR 6.01, 95% CI 1.77-20.48; p = 0.004) and a history of early, previously resolved RN (HR 9.53, 95% CI 2.00-45.61; p = 0.005) remained significantly associated with LRN.

CONCLUSIONS

RN risk persists well beyond 5 years after SRS, and recognizing LRN as an entity has important implications in managing these patients. LRN risk was highest in those with a brain V12Gy > 5 cm3 and a history of early RN after SRS, warranting close follow-up in perpetuity for select patients.

摘要

相似文献

1
Risk of late radiation necrosis more than 5 years after stereotactic radiosurgery.
J Neurosurg. 2024 Nov 1;142(4):1117-1124. doi: 10.3171/2024.6.JNS232187. Print 2025 Apr 1.
2
Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain Metastases.对于接受 5 分数次放射外科治疗的脑转移瘤患者,与放射性坏死相关的剂量学因素。
Pract Radiat Oncol. 2020 Jan-Feb;10(1):36-43. doi: 10.1016/j.prro.2019.09.014. Epub 2019 Oct 3.
3
Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.脑转移瘤立体定向放射治疗后的不良放射效应:发生率、时间进程及危险因素
J Neurosurg. 2015 Aug;123(2):373-86. doi: 10.3171/2014.10.JNS141610. Epub 2015 May 15.
4
Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.单次分割放射外科与分次立体定向放疗治疗脑转移瘤患者的比较研究。
Clin Exp Metastasis. 2020 Jun;37(3):425-434. doi: 10.1007/s10585-020-10031-5. Epub 2020 Mar 17.
5
Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma.立体定向放射外科联合CTLA-4阻断和PD-1抑制治疗转移性黑色素瘤颅内疾病的放射性坏死
J Neurooncol. 2017 Jul;133(3):595-602. doi: 10.1007/s11060-017-2470-4. Epub 2017 May 12.
6
Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery.直线加速器立体定向放射外科后脑放射性坏死的照射体积预测。
Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):996-1001. doi: 10.1016/j.ijrobp.2009.06.006. Epub 2009 Sep 23.
7
Dose-Volume Tolerance of the Brain and Predictors of Radiation Necrosis After 3-Fraction Radiosurgery for Brain Metastases: A Large Single-Institutional Analysis.脑剂量-体积耐受与 3 分次立体定向放疗后脑转移瘤放射性坏死的预测因素:一项大型单机构分析。
Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):275-284. doi: 10.1016/j.ijrobp.2023.07.040. Epub 2023 Sep 8.
8
Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.大小重要吗?研究术后立体定向放射外科治疗切除脑转移瘤的最佳计划靶区边缘。
J Neurosurg. 2019 Mar 1;130(3):797-803. doi: 10.3171/2017.9.JNS171735. Epub 2018 Apr 20.
9
Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From Lung Cancer: A Retrospective Review.肺癌颅内转移立体定向放射外科治疗后放射性坏死范围扩大:一项回顾性研究。
Am J Clin Oncol. 2020 Feb;43(2):128-132. doi: 10.1097/COC.0000000000000642.
10
Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.对既往行放射外科治疗后局部复发的脑转移瘤行重复立体定向放射外科治疗作为挽救性治疗。
J Neurosurg. 2017 Jul;127(1):148-156. doi: 10.3171/2016.5.JNS153051. Epub 2016 Aug 5.

引用本文的文献

1
Intra-cavitary radiotherapy for surgically resected brain metastases: a comprehensive analysis including an individual patient data meta-analysis of intraoperative radiotherapy (IORT) and brachytherapy (IBT).手术切除脑转移瘤的腔内放射治疗:一项综合分析,包括术中放疗(IORT)和近距离放疗(IBT)的个体患者数据荟萃分析。
J Neurooncol. 2025 Sep 17. doi: 10.1007/s11060-025-05227-2.